ArticleJournal of genetics2009
Hope and major strides for genetic diseases of the eye.
Article in Journal of genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Greek Physicians' Skills and Factors Affecting Breaking Bad News to Cancer Patients.Current oncology (Toronto, Ont.) · 2026Article
- Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes.Stem cell research & therapy · 2024Article
- Descriptive Study of a Cohort of 488 Patients with Inherited Retinal Dystrophies.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There have been dramatic advances in the elucidation of the genetic etiology of inherited eye diseases and their underlying pathophysiology in the last two to three decades. This was made possible by the exponential development of powerful molecular biology instrumentation and techniques, the completion of the human genome project, an increasing interest in the study of these diseases worldwide, and a push by the lay public to find cures for these rare but devastating conditions. The genes for a wide range of eye diseases have been identified and have led to a rethinking and a reclassification of disorders that is based not only on classical clinical signs, but also on underlying genetic etiology. Examples of these include the corneal dystrophies, rare forms of strabismus now designated as the cranial dysinnervation disorders, ocular malformations that result from mutations in transcription factors, cataracts that result from mutations in crystallins and other structural lens components, and finally retinal dystrophies that result from defects in phototransduction or visual cycle defects. This article is a perspective on recent advances in the field of ophthalmic genetics.
Indexed as
Identifiers
20090202What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.